Elimination of teicoplanin by adsorption to the filter membrane during haemodiafiltration: Screening experiments for linezolid, teicoplanin and vancomycin followed by in vitro haemodiafiltration models for teicoplanin

Anaesthesia and Intensive Care

Volumn 40, Issue 3, 2012, Pages 442-449

  Shiraishi, Y ^a,b   Okajima, M ^a,c   Sai, Y ^a,d   Miyamoto, K ^a,d   Inaba, H ^a,c  

^a KANAZAWA UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCE   (Japan)

^b KANAZAWA UNIVERSITY   (Japan)

^c Department of Emergency and Critical Care Medicine ^*  (Japan)

^d KANAZAWA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Adsorption; Albumin; Haemodiafiltration; Haemofilters; Methicillin resistant Staphylococcus aureus; Teicoplanin

Indexed keywords

BICARBONATE; HUMAN ALBUMIN; LINEZOLID; POLY(METHYL METHACRYLATE); POLYACRYLONITRILE; POLYSULFONE; TEICOPLANIN; VANCOMYCIN;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG ADSORPTION; DRUG ELIMINATION; DRUG SCREENING; HEMODIAFILTRATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IN VITRO STUDY; MAXIMUM PLASMA CONCENTRATION; MEMBRANE BINDING; MEMBRANE FILTER; PLASMA;

EID: 84861549960     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1204000309     Document Type: Article

References (27)

1. Pea F, Viale P, Pavan F, Furlanut M. Pharmacokinetic considerations for antimicrobial therapy in patients receiving renal replacement therapy. Clin Pharmacokinet 2007; 46:997-1038. (Pubitemid 350136909)
2. Choi G, Gomersall CD, Tian Q, Joynt GM, Freebairn RC, Lipman J. Principles of antibiotic dosing in continuous renal replacement therapy. Crit Care Med 2009; 37:2268-2282.
3. Bressolle F, Kinowski JM, de la Coussaye JE, Wynn N, Eledjam JJ, Galtier M. Clinical pharmacokinetics during continuous haemofiltration. Clin Pharmacokinet 1994; 26:457-471. (Pubitemid 24166335)
4. Reetze-Bonorden P, Bohler J, Keller E. Drug dosage in patients during continuous renal replacement therapy. Pharmacokinetic and therapeutic considerations. Clin Pharmacokinet 1993; 24:362-379. (Pubitemid 23135684)
5. Ulldemolins M, Roberts, JA, Rello J, Paterson DL, Lipman J. The effects of hypoalbuminaemia on optimizing antibacterial dosing in critically ill patients. Clin Pharmacokinet 2011; 50:99-110.
6. Wilson AP. Clinical pharmacokinetics of teicoplanin. Clin Pharmacokinet 2000; 39:167-183.
7. Kroh UF, Dinges GK, Lukasewitz P, Steinhausser WU, Holl TJ, Lennartz H. Elimination of drugs by the new polyamide hemofilter FH77H during various in vitro conditions. Blood Purif 1998; 16:49-56. (Pubitemid 28069963)
8. Tian Q, Gomersall CD, Ip M, Tan PE, Joynt GM, Choi GY. Adsorption of amikacin, a significant mechanism of elimination by hemofiltration. Antimicrob Agents Chemother 2008; 52:1009-1013. (Pubitemid 351358381)
9. Tian Q, Gomersall CD, Wong A, Leung P, Choi G, Joynt GM et al. Effect of drug concentration on adsorption of levofloxacin by polyacrylonitrile haemofilters. Int J Antimicrob Agents 2006; 28:147-150. (Pubitemid 44108618)
10. Oborne CA, Buckton G, Barber N. The interaction of albumin and drugs with two haemofiltration membranes. J Clin Pharm Ther 1994; 19:119-125. (Pubitemid 24207970)
11. Boak LM, Li J, Nation RL, Rayner CR. High-performance liquid chromatographic method for simple and rapid determination of linezolid in human plasma. Biomed Chromatogr 2006; 20:782-786. (Pubitemid 44203174)
12. Hanada K, Kobayashi A, Okamori Y, Kimura T, Ogata H. Improved quantitative determination of total and unbound concentrations of six teicoplanin components in human plasma by high performance liquid chromatography. Biol Pharm Bull 2005; 28:2023-2025. (Pubitemid 41437106)
13. Luksa J, Marusic A. Rapid high-performance liquid chromatographic determination of vancomycin in human plasma. J Chromatogr B Biomed Appl 1995; 667:277-281.
14. Tian Q, Gomersall CD, Leung PP, Choi GY, Joynt GM, Tan PE et al. The adsorption of vancomycin by polyacrylonitrile, polyamide and polysulfone hemofilters. Artificial Organs 2008; 32:81-84.
15. Quale JM, O'Halloran JJ, DeVincenzo N, Barth RH. Removal of vancomycin by high-flux hemodialysis membranes. Antimicrob Agents Chemother 1992; 36:1424-1426.
16. Meyer B, Traunmuller F, Hamwi A, Hollenstein UM, Locker GJ, Sperr WR et al. Pharmacokinetics of teicoplanin during continuous hemofiltration with a new and a 24-h used highly permeable membrane: rationale for therapeutic drug monitoring-guided dosage. Int J Clin Pharmacol Ther 2004; 42:556-560. (Pubitemid 39386796)
17. Wolter K, Claus M, Wagner K, Fritschka E. Teicoplanin pharmacokinetics and dosage recommendations in chronic hemodialysis patients and in patients undergoing continuous veno-venous hemodialysis. Clin Nephrol 1994; 42:389-397.
18. Menth M, Fiegel P. Elimination of teicoplanin via different dialysis membrane: in vitro investigation. Int J Antimicrob Chemother 1992; 1 (Suppl 1):45-48.
19. Thalhammer F, Rosenkranz AR, Burgmann H, Graninger W, Hollenstein U, Schenk P et al. Single-dose pharmacokinetics of teicoplanin during hemodialysis therapy using high-flux polysulfone membranes. Wien Klin Wochenschr 1997; 109:362-365. (Pubitemid 27267235)
20. Yagasaki K, Gando S, Matsuda N, Kameue T, Ishitani T, Hirano T et al. Pharmacokinetics of teicoplanin in critically ill patients undergoing continuous hemodiafiltration. Intensive Care Med 2003; 29:2094-2095. (Pubitemid 37487148)
21. Choi G, Gomersall CD, Lipman J, Wong A, Joynt GM, Leung P et al. The effect of adsorption, filter material and point of dilution on antibiotic elimination by haemofiltration an in vitro study of levofloxacin. Int J Antimicrob Agents 2004; 24:468-472. (Pubitemid 39425159)
22. Inagaki O, Nishian Y, Iwaki R, Nakagawa K, Takamitsu Y, Fujita Y. Adsorption of nafamostat mesilate by hemodialysis membranes. Artif Organs 1992; 16:553-558. (Pubitemid 23027935)
23. Kronfol NO, Lau AH, Barakat MM. Aminoglycoside binding to polyacrylonitrile hemofilter membranes during continuous hemofiltration. ASAIO Trans 1987; 33:300-303.
24. Renaux JL, Thomas M, Crost T, Loughraieb N, Vantard G. Activation of the kallikrein-kinin system in hemodialysis: role of membrane electronegativity, blood dilution, and pH. Kidney Int 1999; 55:1097-1103. (Pubitemid 29100724)
25. Valette P, Thomas M, Dejardin P. Adsorption of low molecular weight proteins to hemodialysis membranes: experimental results and simulations. Biomaterials 1999; 20:1621-1634. (Pubitemid 29391159)
26. Aoike I. Clinical significance of protein adsorbable membranes - long-term clinical effects and analysis using a proteomic technique. Nephrol Dial Transplant 2007; 22 (Suppl 5):13-19.
27. Nakada TA, Oda S, Matsuda K, Sadahiro T, Nakamura M, Abe R et al. Continuous hemodiafiltration with PMMA Hemofilter in the treatment of patients with septic shock. Mol Med 2008; 14:257-263. (Pubitemid 351785698)